Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy

Total metabolic tumor volume on 18F-FDG PET/CT is a game-changer for patients with metastatic lung cancer treated with immunotherapy

Purpose Because of atypical response imaging patterns in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new biomarkers are needed for a better monitoring of treatment efficacy. The aim of this prospective study was to evaluate the progn...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicolas Martin, Pierre Tricarico, David Chardin, Sara Contu, Florent Hugonnet, Josiane Otto, Olivier Humbert
Format: Article
Language:English
Published: BMJ Publishing Group 2024-04-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/12/4/e007628.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items